why choose us

First received: October 31, 2023

Clinical Trial: Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

Study Status: Completed

Recruit Status: RECRUITING

Condition: Thromboembolism

Study Type: INTERVENTIONAL


Official Title: A Pilot Randomized Controlled Trial of Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery

Brief Summary: The aim of this study is to evaluate the feasibility of randomizing individuals to low molecular weight heparin (enoxaparin) or no treatment following cesarean delivery.The investigators hypothesize that among eligible individuals, at least 35% will enroll, undergo randomization, and complete the allocated treatment group.

Read more